Iambic Therapeutics, Inc. (IAM) insider trading
Over the last 12 months, 1 insider bought $11.5M and 0 insiders sold $0 of Iambic Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Oct 16, 2026: Rachlin Evan Lockwood bought 718,750 shares ($11.5M)